HBM Holdings Limited (HKG:2142)
Hong Kong
· Delayed Price · Currency is HKD 12.04
+0.53 (4.60%)
Mar 10, 2026, 1:04 PM HKT
HBM Holdings Revenue
HBM Holdings had revenue of $101.32M USD in the half year ending June 30, 2025, with 147.13% growth. This brings the company's revenue in the last twelve months to $115.71M, up 60.25% year-over-year. In the year 2024, HBM Holdings had annual revenue of $38.10M, down -57.43%.
Revenue (ttm)
$115.71M
Revenue Growth
+60.25%
P/S Ratio
10.59
Revenue / Employee
$551.02K
Employees
210
Market Cap
9.62B HKD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Haohai Biological Technology | 2.75B |
| CStone Pharmaceuticals | 221.89M |
| Abbisko Cayman | 681.17M |
| Lepu Biopharma | 767.54M |
| Everest Medicines | 932.82M |
| Alphamab Oncology | 861.24M |
| CK Life Sciences Int'l., (Holdings) | 5.49B |
| Ascletis Pharma | 2.59M |